Guidelines for abstract submission

Abstract submission: 15 Oct 2025 (29 Aswin 2082)

Instructions for abstract submission

  1. Language. All abstracts should be submitted in English.
  2. Originality. Abstracts should be original and not previously published or presented.
  3. Eligibility. The submitted abstract must describe unpublished work. If it is being considered for publication in any journal, it must be declared.
  4. Formatting: Abstract main text should be typed in Arial font, size 12 or more, spacing at 1.5 lines.
  5. Word limit. The main body of the abstract must not exceed 350 words (this word count does not include abstract title, authors’ details, and keywords). Tables, graphs, and pictures are not counted in the word limit.
  6. Content: The contents of submitted abstract should be structured in the following style:
  1. Abstract Category— Invited lecture / Research Abstracts / Case Report / Case series 
  2. Intended presentation— Oral / Poster
  3. Abstract title – must be in UPPER CASE and limited to 25 words. Please submit symbols as words. e.g. BETA, AND, ALPHA, etc. 
  4. Background and aims:— a brief discussion of the background or rationale of the study and/or questions addressed
  5. Materials and methods: —  the experimental approach, materials, and methods used in the study
  6. Results:— the data and results obtained in the study
  7. Conclusions:— the conclusions and/or implications of the results
  8. Keywords— use up to 5 keywords, separated by commas (e.g., word 1, word 2, word 3). Keywords should be listed in the MeSH terms.
  1. Case Report, Case series should follow this structure:— Background, Case description, Discussion and Clinical importance and learning points 
  2. Images and graphs. Images must be in JPEG or PNG format (uploaded images cannot exceed 1.0 Megabytes). All tables and figures must be accompanied by a caption and list of abbreviations whenever appropriate (e.g., Figure 1: description /Table 1: description). 
  3. Abbreviations. Abbreviations and acronyms should be spelled in full and followed by the abbreviation/acronym in a parenthesis the first time they are mentioned in the abstract. E.g. Systemic lupus erythematosus (SLE) is a rare disease. SLE was diagnosed in 5 out of 10 patients…
  4. Instructions for submission:— 
  1. Abstract should be submitted by the presenting author, who is also the corresponding author and point of contact. 
  2. A separate title page, including the abstract type, abstract title, names of corresponding author, co-authors, their academic titles and affiliations, any declarations should be submitted. The authors’ affiliation should be clearly indicated as Designation, Name of the Department, Name of the Institute, City, Country, email address.
  3. The abstract page, with abstract main text, should contain the abstract type, title and the contents. Author names or author or institutional identifications of any form should not be used in the abstract main text or anywhere in the abstract page.
  1. Restrictions for submission—
  1. Abstract content should not include phone numbers, email or website addresses.
  2. No images, tables, graphs, citations or endnotes are permitted in the abstract main text. Any additional images should be submitted as separate attachments.
  3. Non-proprietary (generic) drug names in small letters must be used wherever possible.
  4. Active promotion of commercial entities, products or services is not permitted.
  5. When using abbreviations, spell out the full name when first cited.
  1. Link for submission: Abstracts must be submitted to the address provided at the end of this document. 
  2. Deadline for submission: Last date for abstract submission is provided at the end of this document.
  3. Presenting author. 
  1. The primary author should ensure that all co-authors are aware of the abstract's content before submission
  2. All presenting authors must register for the conference. Authors not registered for the conference will not be allowed to present their abstract in the conference. 
  3. One individual can represent as the presenting author for a maximum of 2 abstracts.
  1. Co-authors: 
  1. All co-authors must be listed in the title page scientifically in order. If the presenting author isn’t the first author, it should be mentioned in the title page.
  2. All listed co-authors must have reviewed the abstract and accepted responsibility for its contents.
  3. Each author listed should have contributed to the study and consented to be listed. 

 

Outcome of submitted abstracts.

  1. The Scientific committee will make the final decision as to whether the abstract will be accepted for presentation.
  2. The abstracts may be Accepted for either Poster or Mini-oral presentation or Rejected.  The Conference Scientific Committee reserves the right to — 
  • accept or reject any abstract.
  • accept the abstract in a different type of presentation (for example, an abstract submitted for an oral type presentation can be accepted for a poster) than the author had intended to. Due consideration will be given to the author's preference.
  1. The outcome of submission will be communicated to the corresponding author.
  1. Accepted for Poster presentation. For abstracts accepted for poster presentation, poster mounting boards will be provided by the conference organizers. Authors are expected to arrange other accessories, e.g. double tape, adhesives. Board size will be as below: 

Suggested poster size:— 

AO Portrait

841 mm wide x 1189 mm high

33.1 inches wide x 46.8 inches high

  1. Accepted for Mini Oral Presentation. For abstracts accepted for mini oral presentation, a 5 minute slot will be allocated for oral presentation during the conference. It will be followed by a 2 min question answer session. The Scientific Committee can decide to change the time allocated for each mini oral presentation. The presenting author must load the PowerPoint presentations and check for any formatting issues at the AV console at least 1 hour prior to their presentation schedule. Presenters’ computers are not allowed for presentation during the session.
  2. Rejected— Rejected abstracts will not be allowed for presentation in the conference program.
  1. Publication of abstract. 
  1. The Society may publish all accepted abstracts in the official meeting publication in printed form or publish in the electronic audio/visual format in hard drive or as public content on the internet.
  1. As the abstract will be published without any editorial work, please check carefully for typographical errors, misspellings, poor hyphenation, etc. Please check that your abstract title is correct.

 

Originality and Copyrights Transfer

  1. By submitting the abstract of their works, the author(s) represent(s) and warrant(s) that he/she/they is/are the sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, and that the work is original and does not infringe upon any copyright, proprietary, or personal right of any third party. 
  2. The submitter affirms that the work submitted is original, except for extracts from copyrighted works fully authorized by the copyright holders, and that all statements declared as facts are based on thorough examination and investigation for accurateness.
  3. Submitted abstracts should not have been published in any other journals and/or online publications nor presented at any previous international congress.
  4. Submitted abstracts must report new information not previously published or presented at an international scientific meeting prior to the Congress. Note that abstracts previously presented at international meetings will not be accepted unless there is a substantial update of data.
  5. Author(s) retain(s) the right, after presentation at the conference, to subsequently include the work in articles, books, or derivative works that he/she authors or edits.
  6. The submitter signs for all co-authors. He/she accepts responsibility for the present rules for submission and presentation on behalf of all co-authors.
  7. The submitter should have ensured that the patient consent is obtained before submitting the abstract.
  8. The authors consent to have their names, affiliations and biographical material used in connection with the official publication of the conference.

All abstract submitted to: drsimonnepal@gmail.com
Abstract submission deadline: 15 Oct 2025 1159PM NST.